PMD β€” PSYCHEMEDICS CORP

Ownership history in 22NW, LP  Β·  10 quarters on record

This page tracks every 13F SEC filing in which 22NW, LP reported a position in PSYCHEMEDICS CORP (PMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.78% (2023 Q3)
πŸ“Š Avg. % of fund
0.42%
πŸ“… First filed
2020 Q1
πŸ“… Last filed
2025 Q1
⏱ Quarters held
10
% of Fund (quarterly)    PMD price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q1 UNCHANGED 276,034 β€” 0% 0.43% $643K β€”
2024 Q3 ADDED 276,034 +1,616 +0.6% 0.53% $638K β€”
2024 Q2 UNCHANGED 274,418 β€” 0% 0.57% $664K β€”
2024 Q1 UNCHANGED 274,418 β€” 0% 0.69% $804K β€”
2023 Q4 UNCHANGED 274,418 β€” 0% 0.53% $812K β€”
2023 Q3 ADDED 274,418 +198,884 +263.3% 0.78% $1.1M β€”
2020 Q4 REDUCED 75,534 -100 -0.1% 0.14% $384K β€”
2020 Q3 REDUCED 75,634 -6,102 -7.5% 0.17% $334K β€”
2020 Q2 ADDED 81,736 +54,336 +198.3% 0.25% $454K β€”
2020 Q1 INITIATED 27,400 β€” β€” 0.13% $166K β€”
← Back to 22NW, LP Holdings